Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Spruce Biosciences, Inc.
Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
March 13, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
March 13, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 30, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia
January 22, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH
January 05, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024
January 04, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 13, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in the Jefferies London Healthcare Conference
November 02, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasia
October 18, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
August 14, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023)
June 12, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors
May 25, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in the Jefferies Healthcare Conference
May 24, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES Gala
May 22, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 15, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting
May 04, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in May Investor Conferences
May 02, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates
March 16, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference
February 28, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Announces $53.6 Million Private Placement Financing
February 09, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in the SVB Securities Global Biopharma Conference
February 01, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023
January 09, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences and Kaken Pharmaceutical Announce Strategic Partnership and Exclusive Licensing Agreement to Develop and Commercialize Tildacerfont for CAH in Japan
January 05, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Updates
November 10, 2022
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in November Investor Conferences
October 26, 2022
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
August 30, 2022
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 10, 2022
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences to Participate in June Investor Conferences
June 01, 2022
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Announces Acceptance of Abstract for Presentation at ENDO 2022 Annual Conference
May 31, 2022
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Spruce Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 11, 2022
From
Spruce Biosciences, Inc.
Via
Business Wire
Tickers
SPRB
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.